ZBIO
ProShares UltraPro Short Nasdaq BiotechnologyZBIO Fund Description
ZBIO provides -3x daily exposure to a market-cap-weighted index of biotechnology and pharmaceutical companies listed on the NASDAQ.
ZBIO Factset Analytics Insight
ZBIO is the newest inverse play on the NASDAQ Biotechnology Index, this one being -3x the exposure of the daily gains of the index, as opposed to the relatively successful -2x iteration of sister fund BIS. The fund gains its -3x exposure to the index through swap agreements, and rebalances its exposure daily. ZBIO is the second triple-inverse biotech fund, following hot on the heels of Direxion’s LABD, which was launched a month earlier. Like all geared funds that rebalance daily, ZBIO is meant for short-term trading, since compounding effects over the long term could create vast differences from expected returns relative to the index—for good or for ill. Trade this fund with limit orders.
ZBIO CHARTS AND PERFORMANCE
-
1 Month
-
3 Months
-
YTD
-
1 Year
-
3 Years
-
5 Years
-
Max
ZBIO Portfolio Data
ZBIO Fund Structure
ZBIO Tax Exposures
ZBIO Factset Analytics Block Liquidity
This measurement shows how easy it is to trade a $1 million USD block of ZBIO. ZBIO is rated a N/A out of 5.
ZBIO Tradability
The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.
ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.
[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.
Data provider:
Terms of Use